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Identifying genes and mutations in the monogenic inherited skin diseases is 
a challenging task. Discoveries are cherished but often gene-hunting efforts 
have gone unrewarded because technology has failed to keep pace with 
investigators’ enthusiasm and clinical resources. But times are changing. The 
recent arrival of next-generation sequencing has transformed what can now 
be achieved.
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Over the past 20 years, discovering 
the molecular basis of inherited skin 
diseases has been a major challenge 
for geneticists and investigative der-
matologists. Rarely, candidate gene 
approaches—notably, looking for 
specific structural or protein abnor-
malities in the skin of an affected 
individual—have proved incisive for 
some autosomal recessive disorders 
(for example, see Groves et al., 2010). 
For most genodermatoses, however, 
the discovery of inherent gene defects 
has relied on assembling large pedi-
grees or a number of similarly affected 
individuals or families and then 
applying molecular genetic methods 
of genome-wide linkage, homozy-
gosity mapping, fine mapping, and 
gene sequencing (Botstein and Risch, 
2003). Often labor-intensive, slow, 
and inconclusive, optimal “gene hunt-
ing” has desperately needed new 
technology to speed up and simplify 
the work. Thus, the recent advent of 
next-generation sequencing method-
ology, especially exome sequencing, 
has provided a tremendous fillip for 
monogenic disease gene identifica-
tion. Exome sequencing, also known 
as massive parallel sequencing, has 
revolutionized molecular research 
by allowing rapid and cost-effective 
sequencing of the protein-coding 
regions of the genome. Since its intro-
duction into mainstream research in 
2009, more than 50 reports have been 
published on the use of next-gener-
ation sequencing in gene discovery 
projects, several of which are germane 
to inherited skin diseases (Table 1).
Exome sequencing enables the 
protein-coding regions of the human 
genome to be sequenced, and a 
wealth of genetic information can be 
generated. Thousands of mutations in 
the form of single-nucleotide poly-
morphisms and novel variants are 
identified. A key question, however, is 
how to determine the true causal vari-
ants among the hundreds of poten-
tially damaging mutations. Several 
approaches may be used to narrow the 
number of potential candidate genes. 
One technique is to exome sequence 
several affected individuals within the 
pedigree and select common putative 
variants that can then be confirmed by 
dideoxy sequencing; cosegregation 
can be assessed in other affected indi-
viduals within the same family and 
in other unrelated families. Another 
approach is to exome sequence the 
genomic DNA from a single affected 
individual and to compare the result-
ing sequence data with published 
genetic linkage data, if available. 
This strategy may quickly lead to the 
underlying causal variant. Important 
considerations in this approach, 
however, are that the published link-
age data must be robust and that the 
studied pedigree must have the same 
underlying genetic basis (i.e., different 
conditions with a similar phenotype 
must be excluded). A third option is 
to couple exome sequencing with 
homozygosity mapping. This is partic-
ularly useful for the study of rare auto-
somal recessive disorders (Anastasio et 
al., 2010; Bolze et al., 2010; Sirmaci 
et al., 2010; Walsh et al., 2010). In 
the context of an autosomal recessive 
condition with evidence of consan-
guinity, sequencing a single patient 
in combination with homozygosity 
mapping can help focus the search for 
putative causal variants.
Impressive as exome sequencing 
clearly is, it is important to remember 
that often a combination of investi-
gative techniques can be fundamen-
tally important in elucidating the core 
underlying molecular pathology of 
inherited skin diseases. This viewpoint 
is clearly illustrated in a fascinating 
report by Cullinane et al. (this issue, 
2011) that identifies two separate gene 
defects in a single patient with an 
indeterminate phenotype. The features 
of the proband include oculocutaneous 
albinism and congenital neutro-
penia, together consistent with a clini-
cal diagnosis of Hermansky–Pudlak 
syndrome type 2 (HPS-2). After 
excluding mutations in the AP3P1 
gene as the cause of HPS-2 in this 
patient, however, the authors under-
took homozygosity mapping using a 
single-nucleotide polymorphism array 
followed by whole exome sequenc-
ing using the patient’s genomic DNA. 
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Exome sequencing 
enables protein-
coding regions of the 
human genome to be 
sequenced directly.
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This combination of techniques iden-
tified disease-causing mutations in 
two genes: SLC45A2 (giving rise to 
oculocutaneous albin ism type 4; 
Newton et al., 2001) and G6PC3 
(accounting for the neutro penia; 
Boztug et al., 2009). Importantly, this 
study also demonstrated that in the era 
of next-generation sequencing, it may 
not be appropriate to attribute disease 
caus ality to a single genetic defect for 
autosomal recessive Mendelian disor-
ders in which there is a strong history 
of consanguinity. Thus, in this case, 
if a candidate gene approach alone 
had been used to screen for all known 
genes implicated in oculocutaneous 
albinism, only the homo zygous muta-
tion in SLC45A2 would have been iden-
tified. This would not have explained 
why the patient also suffered from 
congenital neutropenia. Conversely, 
if the known genes for congenital 
neutropenia had been screened in iso-
lation and a mutation found in G6PC3, 
this would not have explained why 
the patient also had oculo cutaneous 
albinism. In both scenarios, the wrong 
genotype–phenotype correlation would 
have been made with the potential of 
classifying the patient as having an 
unusual clinical variant of a known 
single disease. Thus, homo zygosity 
mapping followed by exome sequenc-
ing in this patient provided an accurate 
demonstration of the presence of dual 
gene pathology underlying an atypical 
disease phenotype.
The report by Cullinane et al. (2011) 
therefore reminds us that exome 
sequencing, as well as its hypothesis-
free approach to gene/mutation 
identification, has some challenges. 
Moreover, there are some important 
potential technical and logistical 
shortcomings to consider. The human 
exome is ~30 Mb in size and com-
prises ~1% of the human genome, but 
a major caveat of exome sequencing 
is that sequence-capture methods are 
unable to isolate all the exons, and 
hence a proportion of exons will not 
be sequenced. Furthermore, these 
capture methods have limited cover-
age of important regulatory elements 
such as promoters and enhancers (Ku 
et al., 2011). In addition, regions of 
the genome that are poorly annotated 
or yet to be annotated are excluded 
(Ng et al., 2009). These limitations 
must be taken into account because 
they may create problems in identify-
ing causal variants for Mendelian dis-
orders. Nevertheless, it is evident that 
the emergence of exome sequenc-
ing has revolutionized the study of 
rare Mendelian disorders. Provided 
that other gene variant–identifica-
tion methods are not dismissed out 
of hand and consideration is given 
to utilizing a combination of inves-
tigative techniques, the process of 
next-generation gene hunting and 
mutation identification has clearly 
entered an exciting and rewarding 
phase. As further progress is made in 
the annotation of the human genome 
and in the development of better vari-
ant filtering algorithms, next-genera-
tion sequencing will become an even 
more powerful technology in the study 
of genetic disorders, be they rare, 
common, or clinically confusing.
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table 1. Summary of genes identified by next-generation sequencing that underlie mendelian genodermatoses
Disorder Gene Inheritance clinical features reference
Clericuzio-type poikiloderma  
with neutropenia
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Volpi et al., 2010
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Abbreviations: AD, autosomal dominant; AR, autosomal recessive.
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